| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 3e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.24 | 9e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |